BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 37424111)

  • 1. Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer.
    Wang H; Nie C; Luo M; Bai Q; Yao Z; Lv H; Chen B; Wang J; Xu W; Wang S; Chen X
    Bioorg Chem; 2024 Feb; 143():107056. PubMed ID: 38183685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer.
    Bharathiraja P; Yadav P; Sajid A; Ambudkar SV; Prasad NR
    Drug Resist Updat; 2023 Nov; 71():101004. PubMed ID: 37660590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of cisplatin resistance by neferine/isoliensinine and their combinatorial regimens with cisplatin-induced apoptosis in cisplatin-resistant colon cancer stem cells (CSCs).
    Manogaran P; Somasundaram B; Viswanadha VP
    J Biochem Mol Toxicol; 2022 Mar; 36(3):e22967. PubMed ID: 34921482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neferine and isoliensinine enhance 'intracellular uptake of cisplatin' and induce 'ROS-mediated apoptosis' in colorectal cancer cells - A comparative study.
    Manogaran P; Beeraka NM; Huang CY; Vijaya Padma V
    Food Chem Toxicol; 2019 Oct; 132():110652. PubMed ID: 31255669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
    Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
    J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
    Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
    Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug-resistant colon cancer stem cells and induced mitochondria-mediated cell death.
    Manogaran P; Anandan A; Vijaya Padma V
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23395. PubMed ID: 37424111
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.